Hidden Champions (HCs) are firms unknown to the wider public, but global leaders in the niche markets they serve. This paper looks at distinctive features of these firms, focusing on their dynamic capabilities.…
The study looks at the impact of replicability issues in preclinical testing on the medical innovation process. The case study focuses on the development of liposomal chemotherapy, which exemplifies the…